Symbols / INGN $7.15 +2.73% Inogen, Inc.

Healthcare • Medical Devices • United States • NMS
INGN Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Fundamentals
Scroll to Statements
Market Cap 194.71M Enterprise Value 92.61M Income -22.75M Sales 348.67M Book/sh 7.06 Cash/sh 4.39
Dividend Yield — Payout 0.00% Employees 753 IPO — P/E — Forward P/E -23.06
PEG — P/S 0.56 P/B 1.01 P/C — EV/EBITDA -9.70 EV/Sales 0.27
Quick Ratio 2.52 Current Ratio 3.12 Debt/Eq 9.09 LT Debt/Eq — EPS (ttm) -0.86 EPS next Y -0.31
EPS Growth — Revenue Growth 2.00% Earnings 2026-05-06 ROA -6.35% ROE -12.43% ROIC —
Gross Margin 44.24% Oper. Margin -12.21% Profit Margin -6.52% Shs Outstand 27.23M Shs Float 24.01M Short Float 4.16%
Short Ratio 4.29 Short Interest — 52W High 9.13 52W Low 5.34 Beta 1.71 Avg Volume 295.34K
Volume 265.34K Target Price $12.67 Recom Strong_buy Prev Close $6.96 Price $7.15 Change 2.73%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$12.67
Mean price target
2. Current target
$7.15
Latest analyst target
3. DCF / Fair value
$-13.98
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$7.15
Low
$12.00
High
$14.00
Mean
$12.67

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-07 init Freedom Broker — → Buy $12
2025-06-16 init B. Riley Securities — → Buy $14
2025-05-22 up Needham Hold → Buy $12
2025-05-08 main Stifel Hold → Hold $7
2025-04-09 reit Needham Hold → Hold —
2025-02-27 reit Needham Hold → Hold —
2025-02-26 reit Needham Hold → Hold —
2025-01-30 reit Needham Hold → Hold —
2025-01-14 reit Needham Hold → Hold —
2024-11-08 reit Needham — → Hold —
2024-08-07 reit Needham — → Hold —
2024-05-08 main Stifel Hold → Hold $7
2024-05-08 reit Needham — → Hold —
2024-04-09 reit Needham — → Hold —
2024-02-15 up William Blair Market Perform → Outperform —
2023-11-08 main JP Morgan Underweight → Underweight $7
2023-08-08 main Stifel Hold → Hold $8
2023-08-08 down JP Morgan Neutral → Underweight $8
2023-07-14 down Needham Buy → Hold —
2023-04-20 reit Needham — → Buy $26
News
RSS: Latest INGN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-27 BOURQUE MICHAEL J Chief Financial Officer — 29,749 $0.00 $5,331
2026-02-27 BOURQUE MICHAEL J Chief Financial Officer — 42,007 — —
2026-02-27 RAMADE GREGOIRE Officer — 13,005 — —
2026-02-27 SMITH KEVIN RAYMOND MERRILL Chief Executive Officer — 33,410 $0.00 $4,178
2026-02-27 SMITH KEVIN RAYMOND MERRILL Chief Executive Officer — 58,346 — —
2026-02-27 SMITH KEVIN P. General Counsel — 1,500 $6.10 $9,150
2026-02-27 SMITH KEVIN P. General Counsel — 14,005 — —
2026-02-27 YI BOYER JENNIFER M Officer — 3,603 $0.00 $0
2026-02-27 YI BOYER JENNIFER M Officer — 25,017 — —
2026-02-27 WRIGHT MARY E Officer — 2,851 $0.00 $9,150
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
348.67
+3.86%
335.70
+6.35%
315.66
-16.32%
377.24
Operating Revenue
348.67
+3.86%
335.70
+6.35%
315.66
-16.32%
377.24
Cost Of Revenue
194.40
+7.43%
180.96
-4.23%
188.96
-15.53%
223.71
Reconciled Cost Of Revenue
194.40
+7.43%
180.96
-4.23%
188.96
-15.53%
223.71
Gross Profit
154.26
-0.31%
154.74
+22.13%
126.70
-17.48%
153.53
Operating Expense
184.47
-6.48%
197.26
-2.92%
203.19
+8.88%
186.62
Research And Development
19.40
-10.23%
21.61
+3.69%
20.84
-5.03%
21.94
Selling General And Administration
165.07
-6.02%
175.65
-3.68%
182.35
+10.74%
164.67
Selling And Marketing Expense
97.69
-5.22%
103.07
-3.76%
107.09
-11.32%
120.77
General And Administrative Expense
67.38
-7.16%
72.58
-3.56%
75.26
+71.42%
43.91
Other Gand A
67.38
-7.16%
72.58
-3.56%
75.26
+71.42%
43.91
Total Expenses
378.88
+0.17%
378.22
-3.55%
392.15
-4.43%
410.32
Operating Income
-30.21
+28.95%
-42.52
+44.42%
-76.49
-131.22%
-33.08
Total Operating Income As Reported
-30.21
+28.95%
-42.52
+61.13%
-109.39
-28.32%
-85.24
EBITDA
-9.55
+55.62%
-21.51
+63.13%
-58.34
-509.74%
-9.57
Normalized EBITDA
-9.55
+55.62%
-21.51
+15.46%
-25.45
-159.74%
42.59
Reconciled Depreciation
20.66
-1.64%
21.00
+15.71%
18.15
-22.80%
23.51
EBIT
-30.21
+28.95%
-42.52
+44.42%
-76.49
-131.22%
-33.08
Total Unusual Items
0.00
0.00
+100.00%
-32.89
+36.94%
-52.16
Total Unusual Items Excluding Goodwill
0.00
0.00
+100.00%
-32.89
+36.94%
-52.16
Special Income Charges
0.00
0.00
+100.00%
-32.89
+36.94%
-52.16
Impairment Of Capital Assets
—
—
32.89
0.00
Write Off
0.00
0.00
-100.00%
32.89
0.00
Net Income
-22.75
+36.62%
-35.89
+64.97%
-102.45
-22.30%
-83.77
Pretax Income
-23.38
+35.91%
-36.48
+64.36%
-102.34
-22.91%
-83.27
Net Non Operating Interest Income Expense
4.38
-15.51%
5.19
-21.05%
6.57
+131.72%
2.84
Net Interest Income
4.38
-15.51%
5.19
-21.05%
6.57
+131.72%
2.84
Interest Income Non Operating
4.38
-15.51%
5.19
-21.05%
6.57
+131.72%
2.84
Interest Income
4.38
-15.51%
5.19
-21.05%
6.57
+131.72%
2.84
Other Income Expense
2.44
+187.41%
0.85
+102.62%
-32.43
+38.85%
-53.02
Other Non Operating Income Expenses
2.44
+187.41%
0.85
+81.62%
0.47
+154.29%
-0.86
Tax Provision
-0.63
-7.48%
-0.59
-660.00%
0.10
-79.17%
0.50
Tax Rate For Calcs
0.00
+67.70%
0.00
-92.33%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
+100.00%
-6.91
+36.94%
-10.95
Net Income Including Noncontrolling Interests
-22.75
+36.62%
-35.89
+64.97%
-102.45
-22.30%
-83.77
Net Income From Continuing Operation Net Minority Interest
-22.75
+36.62%
-35.89
+64.97%
-102.45
-22.30%
-83.77
Net Income From Continuing And Discontinued Operation
-22.75
+36.62%
-35.89
+64.97%
-102.45
-22.30%
-83.77
Net Income Continuous Operations
-22.75
+36.62%
-35.89
+64.97%
-102.45
-22.30%
-83.77
Normalized Income
-22.75
+36.62%
-35.89
+53.06%
-76.46
-79.64%
-42.56
Net Income Common Stockholders
-22.75
+36.62%
-35.89
+64.97%
-102.45
-22.30%
-83.77
Diluted EPS
-0.86
+43.42%
-1.52
+65.61%
-4.42
-20.44%
-3.67
Basic EPS
-0.86
+43.42%
-1.52
+65.61%
-4.42
-20.44%
-3.67
Basic Average Shares
26.60
+12.46%
23.65
+2.06%
23.18
+1.42%
22.85
Diluted Average Shares
26.60
+12.46%
23.65
+2.06%
23.18
+1.42%
22.85
Diluted NI Availto Com Stockholders
-22.75
+36.62%
-35.89
+64.97%
-102.45
-22.30%
-83.77
Gain On Sale Of PPE
—
0.00
0.00
+100.00%
-52.16
Rent Expense Supplemental
18.77
-4.81%
19.72
+13.11%
17.43
+17.78%
14.80
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
298.62
+0.82%
296.19
-9.20%
326.19
-19.47%
405.04
Current Assets
198.30
+6.93%
185.45
-10.44%
207.07
-32.03%
304.64
Cash Cash Equivalents And Short Term Investments
119.58
+5.08%
113.80
-11.42%
128.47
-31.30%
187.01
Cash And Cash Equivalents
103.73
-8.85%
113.80
-9.32%
125.49
-32.90%
187.01
Cash Equivalents
75.87
-16.39%
90.74
-19.61%
112.88
-29.03%
159.04
Cash Financial
27.86
+20.84%
23.05
+82.80%
12.61
-54.91%
27.97
Other Short Term Investments
15.85
0.00
-100.00%
2.98
0.00
Receivables
38.86
+31.46%
29.56
-31.10%
42.91
-33.32%
64.35
Accounts Receivable
38.86
+31.46%
29.56
-30.01%
42.24
-32.66%
62.73
Gross Accounts Receivable
39.34
+29.27%
30.43
-32.46%
45.06
-28.80%
63.28
Allowance For Doubtful Accounts Receivable
-0.48
+45.12%
-0.87
+69.11%
-2.82
-403.57%
-0.56
Taxes Receivable
—
0.54
-19.58%
0.67
-58.86%
1.63
Inventory
25.97
+4.66%
24.81
+13.61%
21.84
-35.94%
34.09
Raw Materials
14.95
-22.26%
19.22
+6.59%
18.04
-31.93%
26.50
Finished Goods
11.02
+44.43%
7.63
+11.09%
6.87
-26.31%
9.32
Prepaid Assets
—
—
—
—
Restricted Cash
1.29
-64.39%
3.62
0.00
—
Other Current Assets
12.60
-7.76%
13.66
-1.34%
13.85
-27.84%
19.19
Total Non Current Assets
100.33
-9.40%
110.73
-7.05%
119.13
+18.66%
100.40
Net PPE
52.86
-15.68%
62.70
-11.26%
70.65
+8.83%
64.92
Gross PPE
101.83
-5.22%
107.43
-9.34%
118.50
+1.48%
116.77
Accumulated Depreciation
-48.96
-9.45%
-44.73
+6.50%
-47.84
+7.71%
-51.84
Properties
—
—
—
0.00
Land And Improvements
—
—
—
0.12
Machinery Furniture Equipment
—
—
—
12.76
Construction In Progress
—
—
—
2.93
Other Properties
101.83
-5.22%
107.43
-9.34%
118.50
+1.48%
116.77
Leases
—
—
—
6.13
Goodwill And Other Intangible Assets
41.46
+3.76%
39.96
-10.50%
44.65
+35.18%
33.03
Goodwill
10.70
+13.03%
9.46
-5.89%
10.06
-69.39%
32.85
Other Intangible Assets
30.76
+0.89%
30.49
-11.85%
34.59
+19442.94%
0.18
Non Current Deferred Assets
—
—
—
—
Non Current Deferred Taxes Assets
—
—
—
—
Other Non Current Assets
6.00
-25.73%
8.08
+111.27%
3.83
+56.44%
2.44
Total Liabilities Net Minority Interest
106.39
-13.02%
122.33
+0.78%
121.38
+12.77%
107.64
Current Liabilities
63.53
-17.15%
76.69
+5.78%
72.50
+10.94%
65.35
Payables And Accrued Expenses
44.75
+0.60%
44.48
+7.88%
41.23
-8.70%
45.16
Payables
20.82
+24.24%
16.76
+24.31%
13.48
-28.02%
18.73
Accounts Payable
20.26
+21.95%
16.62
+23.50%
13.45
-26.23%
18.24
Other Payable
0.37
—
—
—
Current Accrued Expenses
23.93
-13.68%
27.73
-0.10%
27.75
+4.99%
26.43
Total Tax Payable
0.18
+28.87%
0.14
+425.93%
0.03
-94.51%
0.49
Income Tax Payable
0.18
+28.87%
0.14
+425.93%
0.03
0.00
Current Debt And Capital Lease Obligation
3.16
+12.48%
2.81
-23.02%
3.65
+3.93%
3.52
Current Capital Lease Obligation
3.16
+12.48%
2.81
-23.02%
3.65
+3.93%
3.52
Current Deferred Liabilities
5.50
-17.30%
6.65
-16.62%
7.98
-10.14%
8.88
Current Deferred Revenue
5.50
-17.30%
6.65
-16.62%
7.98
-10.14%
8.88
Other Current Liabilities
—
13.00
+30.00%
10.00
—
Total Non Current Liabilities Net Minority Interest
42.86
-6.09%
45.64
-6.64%
48.89
+15.61%
42.29
Long Term Debt And Capital Lease Obligation
14.31
-13.75%
16.59
-9.17%
18.27
-7.56%
19.76
Long Term Capital Lease Obligation
14.31
-13.75%
16.59
-9.17%
18.27
-7.56%
19.76
Long Term Provisions
18.19
+11.28%
16.35
+18.05%
13.85
+14.25%
12.12
Non Current Deferred Liabilities
10.35
-18.46%
12.70
-24.28%
16.77
+61.23%
10.40
Non Current Deferred Revenue
3.60
-37.31%
5.75
-30.14%
8.23
-20.89%
10.40
Non Current Deferred Taxes Liabilities
6.75
-2.86%
6.95
-18.63%
8.54
0.00
Other Non Current Liabilities
—
—
—
—
Stockholders Equity
192.23
+10.57%
173.86
-15.11%
204.81
-31.13%
297.41
Common Stock Equity
192.23
+10.57%
173.86
-15.11%
204.81
-31.13%
297.41
Capital Stock
0.03
+12.50%
0.02
+4.35%
0.02
+0.00%
0.02
Common Stock
0.03
+12.50%
0.02
+4.35%
0.02
+0.00%
0.02
Share Issued
27.23
+13.93%
23.90
+4.19%
22.94
+0.00%
22.94
Ordinary Shares Number
27.23
+13.93%
23.90
+4.19%
22.94
+0.00%
22.94
Additional Paid In Capital
363.55
+10.78%
328.17
+2.39%
320.51
+2.69%
312.13
Retained Earnings
-175.58
-14.88%
-152.84
-30.69%
-116.95
-706.54%
-14.50
Gains Losses Not Affecting Retained Earnings
4.24
+382.68%
-1.50
-222.53%
1.23
+604.12%
-0.24
Other Equity Adjustments
4.24
+382.68%
-1.50
-222.53%
1.23
+604.12%
-0.24
Total Equity Gross Minority Interest
192.23
+10.57%
173.86
-15.11%
204.81
-31.13%
297.41
Total Capitalization
192.23
+10.57%
173.86
-15.11%
204.81
-31.13%
297.41
Working Capital
134.76
+23.90%
108.77
-19.18%
134.57
-43.76%
239.30
Invested Capital
192.23
+10.57%
173.86
-15.11%
204.81
-31.13%
297.41
Total Debt
17.48
-9.95%
19.41
-11.48%
21.92
-5.82%
23.28
Capital Lease Obligations
17.48
-9.95%
19.41
-11.48%
21.92
-5.82%
23.28
Net Tangible Assets
150.77
+12.60%
133.90
-16.40%
160.16
-39.42%
264.38
Tangible Book Value
150.77
+12.60%
133.90
-16.40%
160.16
-39.42%
264.38
Current Provisions
10.12
+3.90%
9.74
+1.12%
9.63
+23.59%
7.79
Inventories Adjustments Allowances
—
-2.04
+33.32%
-3.07
-77.59%
-1.73
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-11.22
-289.65%
5.91
+282.87%
-3.23
+91.38%
-37.53
Cash Flow From Continuing Operating Activities
-11.22
-289.65%
5.91
+282.87%
-3.23
+91.38%
-37.53
Net Income From Continuing Operations
-22.75
+36.62%
-35.89
+64.97%
-102.45
-22.30%
-83.77
Depreciation Amortization Depletion
20.66
-1.64%
21.00
+15.71%
18.15
-22.80%
23.51
Depreciation And Amortization
20.66
-1.64%
21.00
+15.71%
18.15
-22.80%
23.51
Other Non Cash Items
0.43
-87.44%
3.45
-61.17%
8.88
+157.71%
-15.39
Stock Based Compensation
8.01
+8.34%
7.40
-0.40%
7.43
-39.53%
12.28
Provisionand Write Offof Assets
7.17
-35.51%
11.12
-17.12%
13.42
-13.12%
15.45
Asset Impairment Charge
0.00
0.00
-100.00%
32.89
0.00
Deferred Tax
-1.10
+4.35%
-1.15
-358.17%
-0.25
0.00
Deferred Income Tax
-1.10
+4.35%
-1.15
-358.17%
-0.25
0.00
Operating Gains Losses
3.27
-25.29%
4.37
-1.22%
4.42
-91.97%
55.10
Gain Loss On Sale Of PPE
0.06
+134.55%
-0.17
-96.43%
-0.08
-100.16%
52.01
Change In Working Capital
-26.91
-513.05%
-4.39
-130.77%
14.27
+131.91%
-44.72
Change In Receivables
-14.62
-188.61%
-5.07
-145.53%
11.13
+121.56%
-51.62
Changes In Account Receivables
-14.62
-181.94%
-5.19
-151.15%
10.14
+119.75%
-51.34
Change In Inventory
-3.21
+9.27%
-3.54
-144.91%
7.88
+240.65%
-5.60
Change In Prepaid Assets
1.30
-46.16%
2.41
-56.82%
5.58
-17.93%
6.80
Change In Payables And Accrued Expense
-1.11
-137.84%
2.92
+130.27%
-9.66
-1791.42%
0.57
Change In Accrued Expense
-6.75
-208.49%
6.22
+1324.80%
-0.51
+91.68%
-6.11
Change In Payable
5.64
+271.08%
-3.30
+63.95%
-9.15
-237.04%
6.68
Change In Account Payable
5.60
+263.97%
-3.41
+62.80%
-9.18
-235.77%
6.76
Change In Other Working Capital
-1.07
+10.60%
-1.20
-344.49%
0.49
-90.27%
5.04
Change In Other Current Assets
4.93
+11.94%
4.41
+91.27%
2.30
-33.88%
3.48
Change In Other Current Liabilities
-13.13
-203.54%
-4.33
-25.17%
-3.46
-1.80%
-3.40
Investing Cash Flow
-26.21
-87.54%
-13.97
+76.44%
-59.31
-445.32%
-10.88
Cash Flow From Continuing Investing Activities
-26.21
-87.54%
-13.97
+76.44%
-59.31
-445.32%
-10.88
Net PPE Purchase And Sale
-10.38
+30.79%
-15.00
+43.42%
-26.52
-24.95%
-21.22
Purchase Of PPE
-10.38
+30.79%
-15.00
+43.42%
-26.52
-24.95%
-21.22
Capital Expenditure
-10.38
+39.26%
-17.09
+36.72%
-27.01
-27.28%
-21.22
Net Investment Purchase And Sale
-15.83
-656.67%
2.84
+199.09%
-2.87
-128.65%
10.01
Purchase Of Investment
-29.83
+8.66%
-32.66
-21.54%
-26.87
0.00
Sale Of Investment
14.00
-60.55%
35.50
+47.92%
24.00
+139.66%
10.01
Net Business Purchase And Sale
0.00
0.00
+100.00%
-29.63
0.00
Purchase Of Business
0.00
0.00
+100.00%
-29.63
0.00
Net Intangibles Purchase And Sale
0.00
+100.00%
-2.09
-323.08%
-0.49
0.00
Purchase Of Intangibles
0.00
+100.00%
-2.09
-323.08%
-0.49
0.00
Net Other Investing Changes
—
0.28
+38.89%
0.20
-40.18%
0.33
Financing Cash Flow
24.18
+9025.28%
0.27
-72.40%
0.96
+152.63%
0.38
Cash Flow From Continuing Financing Activities
24.18
+9025.28%
0.27
-72.40%
0.96
+152.63%
0.38
Net Common Stock Issuance
27.21
0.00
0.00
—
Proceeds From Stock Option Exercised
0.97
+19.73%
0.81
-45.13%
1.48
-14.81%
1.74
Net Other Financing Charges
-4.00
-632.42%
-0.55
-5.41%
-0.52
+61.77%
-1.35
Changes In Cash
-13.24
-69.87%
-7.80
+87.34%
-61.59
-28.23%
-48.03
Effect Of Exchange Rate Changes
0.85
+401.07%
-0.28
-519.40%
0.07
+113.93%
-0.48
Beginning Cash Position
117.42
-6.44%
125.49
-32.90%
187.01
-20.60%
235.52
End Cash Position
105.02
-10.56%
117.42
-6.44%
125.49
-32.90%
187.01
Free Cash Flow
-21.60
-93.21%
-11.18
+63.04%
-30.25
+48.52%
-58.75
Income Tax Paid Supplemental Data
0.32
-14.67%
0.38
—
0.50
Change In Income Tax Payable
0.05
-60.00%
0.12
+325.93%
0.03
+132.93%
-0.08
Change In Tax Payable
0.05
-60.00%
0.12
+325.93%
0.03
+132.93%
-0.08
Common Stock Issuance
27.21
0.00
0.00
—
Issuance Of Capital Stock
27.21
0.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category